Ketamine: clinical trials recruiting now
26
Recruiting trials
15
Conditions studied
11
US states with sites
6
Countries
FDA drug label
- FDA-approved
- Yes. Ketamine appears in the FDA drug-label database. Marketed as Ketalar.
FDA-approved use
KETALAR (ketamine hydrochloride) injection is indicated: as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. for the induction of anesthesia prior to the administration of other general anesthetic agents. as a supplement to other anesthetic agents. KETALAR is a general anesthetic indicated: as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation ( 1 ) for the induction of anesthesia prior to the administration of other general anesthetic agents ( 1 ) as a supplement to other anesthetic agents ( 1 ).
Phase breakdown
Early Phase 1 1
Phase 1 5
Phase 2 8
Phase 3 4
Phase 4 5
Not applicable 4
Conditions being studied
Recruiting trials involving Ketamine
- ACT_for Alcohol Use Disorder and Depression
- Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
- ECT with Ketamine Anesthesia Vs High Intensity Ketamine with ECT Rescue for Treatment-Resistant Depression
- Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients
- Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine
- Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
- Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
- Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
- Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
- InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpression
- Intravenous Ketamine for Treatment-Resistant Depression
- Ketamine Alcohol (in Treatment-Resistant Depression)
- Ketamine Treatment Plans for Chronic Conditions
- Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
- Ketamine for Veterans With Parkinson's Disease
- Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
- Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
- Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches
- Neural Circuit Effects of Ketamine in Depression
- Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
- Pharmacologic Treatment Augmentation in Chronic Depression
- Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic Kids (PEAK-SEEK)
- RIVER At Home Ketamine Protocols
- The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
- Understanding Ketamine's Dissociative Effects (KD Study)
- University of Iowa Interventional Psychiatry Service Patient Registry
Common questions
Is Ketamine FDA-approved?
Yes, marketed as Ketalar.
How many recruiting trials involve Ketamine?
26 recruiting trials across 15 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.